D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Mizuho Financial
MFG
$129B
| $813K | ﹤0.01% |
265,774
-182,403
| -41% | -$571K |
|
2677
CALL
Warner Bros
WBD
$63.4B
| $811K | ﹤0.01% |
30,000
-38,800
| -56% | -$1.08M |
|
2678
Scansource
SCSC
$1.13B
| $810K | ﹤0.01% |
+22,600
| New | +$845K |
|
2679
TransAlta
TAC
$4.25B
| $810K | ﹤0.01% |
110,200
-19,100
| -15% | -$109K |
|
2680
Atlanta Braves Holdings Series B
BATRK
$3.25B
| $809K | ﹤0.01% |
29,126
-6,135
| -17% | -$169K |
|
2681
TransDigm Group
TDG
$71.9B
| $809K | ﹤0.01% |
1,782
+782
| +78% | +$317K |
|
|
BMTC
2682
DELISTED
Bryn Mawr Bank Corp
BMTC
| $807K | ﹤0.01% |
22,349
-14,985
| -40% | -$568K |
|
2683
Domino's
DPZ
$11.4B
| $805K | ﹤0.01% |
3,119
-4,269
| -58% | -$1.11M |
|
|
AL
2684
PUT
DELISTED
Air Lease Corp
AL
| $804K | ﹤0.01% |
23,400
+12,300
| +111% | +$444K |
|
2685
Exelixis
EXEL
$14B
| $804K | ﹤0.01% |
33,794
-83,184
| -71% | -$1.9M |
|
|
ENZ
2686
DELISTED
Enzo Biochem, Inc.
ENZ
| $802K | ﹤0.01% |
293,953
+55,588
| +23% | +$182K |
|
|
FBM
2687
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $795K | ﹤0.01% |
80,840
+15,698
| +24% | +$152K |
|
2688
TriplePoint Venture Growth BDC
TPVG
$182M
| $794K | ﹤0.01% |
+57,736
| New | +$736K |
|
|
GBT
2689
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $794K | ﹤0.01% |
15,000
| – | – |
|
|
CZZ
2690
DELISTED
Cosan Limited
CZZ
| $794K | ﹤0.01% |
68,475
-25,901
| -27% | -$285K |
|
2691
Silicom
SILC
$226M
| $791K | ﹤0.01% |
20,676
+11,088
| +116% | +$402K |
|
2692
Theravance Biopharma
TBPH
$874M
| $791K | ﹤0.01% |
34,871
-40,163
| -54% | -$1.02M |
|
|
LDL
2693
PUT
DELISTED
Lydall, Inc.
LDL
| $791K | ﹤0.01% |
33,700
| – | – |
|
|
MSGN
2694
DELISTED
MSG Networks Inc.
MSGN
| $791K | ﹤0.01% |
36,353
+2,565
| +8% | +$59.1K |
|
2695
FTI Consulting
FCN
$4.88B
| $784K | ﹤0.01% |
10,206
-11,316
| -53% | -$799K |
|
2696
Dave & Buster's
PLAY
$363M
| $783K | ﹤0.01% |
+15,708
| New | +$771K |
|
|
UNIT
2697
PUT
Uniti Group
UNIT
$2.62B
| $783K | ﹤0.01% |
70,000
-8,000
| -10% | -$117K |
|
|
ZEUS
2698
DELISTED
Olympic Steel
ZEUS
| $783K | ﹤0.01% |
49,314
-14,823
| -23% | -$266K |
|
2699
CALL
Ashland
ASH
$3.04B
| $781K | ﹤0.01% |
10,000
| – | – |
|
|
QADA
2700
DELISTED
QAD Inc.
QADA
| $780K | ﹤0.01% |
18,112
-16,364
| -47% | -$702K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.